Status:
COMPLETED
A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
Lead Sponsor:
AstraZeneca
Conditions:
COPD
Chronic Diseases
Eligibility:
All Genders
35+ years
Brief Summary
The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance ...
Eligibility Criteria
Inclusion
- COPD diagnose, verified by spirometry
- Having given informed consent
Exclusion
- \-
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
936 Patients enrolled
Trial Details
Trial ID
NCT00772733
Start Date
October 1 2008
End Date
December 1 2010
Last Update
February 23 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aarhus, Arhus, Denmark
2
Research Site
Bjerringbro, Viborg, Denmark
3
Research Site
Møldrup, Viborg, Denmark
4
Research Site
Skals, Viborg, Denmark